KNE Share Price

Open 0.02 Change Price %
High 0.02 1 Day 0.00 0.00
Low 0.02 1 Week 0.00 0.00
Close 0.02 1 Month 0.00 0.00
Volume 9000 1 Year -0.04 -66.67
52 Week High 0.06
52 Week Low 0.02
KNE Important Levels
Resistance 2 0.02
Resistance 1 0.02
Pivot 0.02
Support 1 0.02
Support 2 0.02
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
BGS 0.03 200.00%
BGS 0.03 200.00%
BTT 0.09 125.00%
BTT 0.09 125.00%
BTT 0.09 125.00%
FGC 0.02 100.00%
FGC 0.02 100.00%
BVQ 0.02 100.00%
PPE 0.02 100.00%
AZU 0.02 100.00%
More..
CVE Canada Top Losers Stocks
AHP 0.04 -60.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
ELN 0.02 -33.33%
More..

Kane Biotech Inc (CVE: KNE)

KNE Technical Analysis 5
As on 12th Jan 2017 KNE Share Price closed @ 0.02 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.04 & Strong Sell for SHORT-TERM with Stoploss of 0.02 we also expect STOCK to react on Following IMPORTANT LEVELS.
KNE Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
KNE Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.kanebiotech.com
KNE Address
KNE
162-196 Innovation Drive
Winnipeg, MB R3T 2N2
Canada
Phone: 204-453-1301
Fax: 204-474-7552
KNE Latest News
Philip Renaud Files Early Warning Report in Respect of Kane Biotech Inc.   Marketwired (press release)   - 06th May 16
Kane Biotech Announces Rights Offering   Marketwired (press release)   - 30th Mar 16
City biotech firm hopes to take bite out of pet-care industry in U.S.   Winnipeg Free Press   - 15th Mar 16
Kane Biotech Expanding Bluestem to the US   PetProductNews.com   - 03rd Mar 16
Monday Deal Review - November 3, 2015   Proactive Investors USA & Canada (blog)   - 04th Nov 15
Ahrens-Townsend named new CEO of Kane Biotech   Winnipeg Free Press   - 12th May 15
Kane Biotech Introduces bluestem(TM)   Marketwired (press release)   - 12th Feb 15
Kane Biotech Appoints Dr. Sarah Prichard, MD to the Board of Directors   Marketwired (press release)   - 02nd Apr 14
City firm banishes doggie breath   Winnipeg Free Press   - 02nd Feb 13
A Canadian Biotech Company Aims To Speed Up Wound Healing   Business Insider   - 19th Jul 11
Interactive Technical Analysis Chart Kane Biotech Inc ( KNE CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Kane Biotech Inc
KNE Business Profile
Kane Biotech Inc., a biotechnology company, is engaged in the development and commercialization of products to prevent and remove biofilms. Its products include DispersinB, an antibiofilm enzyme for the wound care market; Aledex for the medical device coating market; KBI antibacterial disinfectant; and StrixNB for the oral care market. The company was founded in 2001 and is based in Winnipeg, Canada.